The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Epigenetic Determinants of Cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetic and epigenetic alterations are known to play a key role in silencing of tumor suppressor genes34,35.”
From Gadd45g insufficiency drives the pathogenesis of myeloproliferative neoplasms (2024) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945 · cited 2×
“These latter include not only standard chemotherapies, but also, intriguingly, an exciting new immunotherapy (Brahmer et al. 2012; Topalian et al. 2012), which targets breaking lymphocyte immune tolerance to render these cells immune competent (Wrangle et al. 2013).”
BackgroundVogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Self-citationHuman DNA methylomes at base resolution show widespread epigenomic differences
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
Research works printed but not linked: 245
- 10.1172/JCI69736 · DOI
- 10.1101/cshperspect.a018739 · DOI
- 10.1101/cshperspect.a019372 · DOI
- 10.1128/MCB.21.19.6470-6483.2001 · DOI
- 10.1016/j.jcis.2009.07.024 · DOI
- 2013, DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases, Sci Transl Med, 5, 169ra110
- 10.1101/cshperspect.a019521 · DOI
- 10.1038/nrclinonc.2013.42 · DOI
- 10.1074/jbc.M104661200 · DOI
- 10.1016/S1535-6108(02)00234-9 · DOI
- 10.1016/j.cell.2006.11.052 · DOI
- 10.1373/clinchem.2009.140244 · DOI
- 10.1158/0008-5472.CAN-07-0065 · DOI
- 10.1101/cshperspect.a018382 · DOI
- 10.1016/j.cell.2010.10.012 · DOI · Paper page
- 1987, Hypermethylation of the 5′ region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies, Blood, 70, 412, 10.1182/blood.V70.2.412.412 · DOI
- 10.1158/0008-5472.CAN-10-3184 · DOI
- 10.1101/cshperspect.a019463 · DOI
- 10.1101/sqb.2005.70.051 · DOI · Paper page
- 10.1038/ng.969 · DOI · Paper page
- 10.1016/j.ccr.2011.06.010 · DOI
- 10.1016/j.ccr.2012.11.006 · DOI
- 10.18632/oncotarget.1408 · DOI
- 10.1016/j.pharmthera.2014.04.004 · DOI
- 10.1126/science.1147939 · DOI
- 10.1038/sj.emboj.7600509 · DOI
- 10.1101/gad.1640908 · DOI
- 10.1056/NEJMoa0706550 · DOI
- 10.1093/jnci/93.9.691 · DOI
- 10.1038/onc.2013.178 · DOI
- 10.1038/5047 · DOI
- 10.1007/978-1-59745-522-0_23 · DOI
- 10.1038/nature11247 · DOI · Paper page
- 10.1016/0006-2952(83)90293-9 · DOI
- 10.1016/j.cell.2013.06.005 · DOI
- 10.1101/gad.217778.113 · DOI · Paper page
- 10.1158/1078-0432.CCR-10-2156 · DOI
- 10.1038/25779 · DOI
- 10.1038/ng1077 · DOI
- 10.1016/j.ccr.2004.08.030 · DOI
- 10.1016/j.cell.2005.08.011 · DOI
- 10.1101/cshperspect.a018747 · DOI
- 10.1126/science.1166261 · DOI
- 10.1158/1535-7163.MCT-05-0172 · DOI
- 10.1093/nar/gks031 · DOI
- 10.1158/2159-8290.CD-13-0117 · DOI
- 10.1016/j.ccr.2011.06.009 · DOI
- 10.1038/77083 · DOI
- 10.1182/blood.V100.8.2957 · DOI
- 10.1016/j.cell.2012.06.013 · DOI · Paper page
- 10.1038/nature10509 · DOI
- 10.1056/NEJMra1112635 · DOI
- 10.1016/j.tcb.2010.08.003 · DOI
- 2010, Genetics of basal cell carcinoma, Australasian J Dermatol, 51, 81, 10.1111/j.1440-0960.2009.00579.x · DOI
- 10.2217/epi.11.105 · DOI · Paper page
- 10.1016/j.cell.2011.08.017 · DOI
- 10.1126/science.1065173 · DOI
- 10.1038/ncb2038 · DOI
- 10.1101/gr.131169.111 · DOI
- 10.1007/978-1-4419-9967-2_2 · DOI
- 10.1093/nar/10.8.2709 · DOI
- 10.1038/nchembio.1107 · DOI
- 10.1038/nrg2005 · DOI
- 10.1056/NEJMra072067 · DOI
- 10.1056/NEJM200011093431901 · DOI
- 10.1093/hmg/10.26.3001 · DOI
- 2001, Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis, Cancer Res, 61, 4689
- 2002, Dependence of histone modifications and gene expression on DNA hypermethylation in cancer, Cancer Res, 62, 7213
- 10.1038/301089a0 · DOI
- 10.1073/pnas.94.13.6770 · DOI
- 10.1016/0092-8674(93)90546-3 · DOI
- 10.1158/1535-7163.MCT-13-0770 · DOI
- 10.1128/MCB.4.10.2098 · DOI
- 1984, Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study, Am Rev Respir Dis, 130, 549
- 10.1038/71750 · DOI
- 10.1093/emboj/20.10.2536 · DOI · Paper page
- 10.1093/nar/gkg332 · DOI
- 10.1073/pnas.0806437105 · DOI
- 10.1097/CCO.0b013e328313699c · DOI
- 10.1016/j.cell.2013.03.002 · DOI
- 2002, A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor, Cancer Res, 62, 3925
- 10.1128/MCB.25.11.4727-4741.2005 · DOI
- 10.1158/0008-5472.CAN-06-0080 · DOI
- 10.1038/79120 · DOI
- 1994, Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis, Cancer Res, 54, 4855
- 10.1101/cshperspect.a019331 · DOI
- 10.1097/PAS.0b013e318212782a · DOI
- 10.1038/ng.907 · DOI
- 10.1158/0008-5472.CAN-08-1957 · DOI
- 10.1038/nature11404 · DOI · Paper page
- 10.1038/ng.865 · DOI
- 10.1038/nbt.1682 · DOI
- 10.1056/NEJMoa043331 · DOI · Paper page
- 10.1056/NEJMra023075 · DOI
- 10.1073/pnas.93.18.9821 · DOI
- 10.1073/pnas.95.12.6870 · DOI
- 10.1101/gr.117523.110 · DOI
- 10.1016/j.ccr.2011.07.003 · DOI
- 10.1016/j.ccr.2005.09.007 · DOI
- 2003, Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia, Cancer Res, 63, 1596
- 10.1101/gr.125872.111 · DOI · Paper page
- 10.1089/gtmb.2012.0478 · DOI
- 10.1136/gutjnl-2012-304219 · DOI
- 10.1182/blood-2003-03-0687 · DOI
- 10.1093/abbs/gmp040 · DOI
- 10.1038/nrg3230 · DOI · Paper page
- 2002, The fundamental role of epigenetic events in cancer, Nat Rev Genet, 3, 415, 10.1038/nrg816 · DOI · Paper page
- 10.1016/j.cell.2007.01.029 · DOI · Paper page
- 10.1038/5947 · DOI
- 10.1038/nrg2651 · DOI
- 10.1126/science.1196333 · DOI
- 10.1158/2159-8290.CD-11-0214 · DOI
- 10.1158/1078-0432.CCR-04-2135 · DOI
- 10.1016/S0304-3835(02)00689-4 · DOI
- 10.1158/0008-5472.CAN-05-2959 · DOI
- 1999, Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies, Blood, 93, 4347, 10.1182/blood.V93.12.4347 · DOI
- 10.1038/nbt.1678 · DOI
- 10.1101/gr.143008.112 · DOI · Paper page
- 10.1111/j.1365-2559.2011.03819.x · DOI
- 10.1038/386761a0 · DOI · Paper page
- 10.1038/35101031 · DOI
- 10.1128/MCB.23.1.206-215.2003 · DOI
- 10.1101/cshperspect.a018630 · DOI
- 10.1038/ng.2443 · DOI
- 10.1073/pnas.0409875102 · DOI · Paper page
- 10.1038/nrc1045 · DOI
- 10.1016/0092-8674(95)90329-1 · DOI
- 10.1016/0006-291X(79)92015-1 · DOI
- 10.1073/pnas.91.24.11733 · DOI
- 2003, Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation, Cancer Res, 63, 6110
- 10.18632/oncotarget.1782 · DOI
- 10.1101/cshperspect.a019133 · DOI
- 10.1038/ng.903 · DOI
- 10.1038/nature09798 · DOI
- 10.1038/ng0195-48 · DOI
- 10.1101/gad.217406.113 · DOI · Paper page
- 10.1101/gad.226753.113 · DOI
- 2000, DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: Clinical results and possible mechanisms of action, Curr Top Microbiol Immunol, 249, 135
- 10.1016/j.stem.2010.11.013 · DOI
- 10.1101/gr.157529.113 · DOI
- 10.1038/35106079 · DOI · Paper page
- 10.1101/cshperspect.a018762 · DOI
- 10.1038/sj.leu.2404050 · DOI
- 10.1038/modpathol.2013.86 · DOI
- 10.1038/onc.2008.499 · DOI
- 10.1158/0008-5472.CAN-08-0700 · DOI
- 10.1093/hmg/ddm021 · DOI
- 10.1038/sj.onc.1205402 · DOI
- 10.1002/(SICI)1097-0215(19980911)77:6<833::AID-IJC6>3.0.CO;2-V · DOI
- 10.1126/science.1101731 · DOI
- 10.1093/nar/29.22.4598 · DOI
- 10.1016/j.trsl.2014.04.001 · DOI
- 10.1038/nature12488 · DOI
- 10.1016/j.ccr.2010.03.017 · DOI · Paper page
- 10.1016/j.ccr.2011.09.012 · DOI
- 10.1101/cshperspect.a018754 · DOI
- 10.1101/sqb.2010.75.014 · DOI
- 10.1016/j.molcel.2010.03.016 · DOI · Paper page
- 2000, Mutation hotspots and DNA methylation, Curr Top Microbiol Immunol, 249, 1
- 10.1101/cshperspect.a019547 · DOI
- 10.1158/2159-8290.CD-12-0076 · DOI
- 10.1200/JCO.2013.50.3102 · DOI
- 10.1158/2159-8290.CD-11-0209 · DOI
- 10.1101/cshperspect.a018663 · DOI
- 10.1371/journal.pone.0023372 · DOI
- 1995, Loss of imprinting in hepatoblastoma, Cancer research, 55, 1836
- 10.1038/362747a0 · DOI
- 10.1200/JCO.2009.24.9094 · DOI
- 10.1002/bies.201300130 · DOI
- 10.1016/j.semcancer.2012.12.001 · DOI
- 10.1038/35010000 · DOI
- 10.1038/416552a · DOI · Paper page
- 2002, Histone deacetylase inhibitors: A new class of potential therapeutic agents for cancer treatment, Clin Cancer Res, 8, 662
- 10.1126/science.1697983 · DOI
- 10.1038/77124 · DOI · Paper page
- 10.1038/35054579 · DOI · Paper page
- 10.1038/ng1773 · DOI
- 10.1177/1947601911417976 · DOI
- 10.1038/77023 · DOI
- 10.4161/cc.5.19.3340 · DOI
- 10.1016/j.ccr.2006.04.020 · DOI
- 1991, Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene, Am J Hum Genet, 48, 880
- 10.1126/science.1108080 · DOI
- 10.1007/s00018-011-0892-2 · DOI
- 10.1038/ncponc0812 · DOI
- 10.1073/pnas.81.22.6993 · DOI
- 10.1101/cshperspect.a018671 · DOI
- 10.1101/gad.590910 · DOI
- 2007, Comparing the DNA hypermethylome with gene mutations in human colorectal cancer, PLoS Genet, 3, 1709
- 10.1101/cshperspect.a018713 · DOI
- 10.1016/j.cell.2010.02.027 · DOI · Paper page
- 10.1016/j.cell.2013.03.008 · DOI
- 10.1212/01.WNL.0000042422.87384.2F · DOI
- 10.1200/JCO.2002.04.117 · DOI
- 10.1002/cmdc.200900301 · DOI
- 10.1073/pnas.1013224108 · DOI · Paper page
- 10.1186/gb-2012-13-10-r84 · DOI · Paper page
- 10.1126/science.145.3632.548 · DOI
- 10.1182/blood-2009-06-227660 · DOI
- 10.1002/pros.20521 · DOI
200 of 245 shown
Cited by
Hallmarks of Cancer: New Dimensions
Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887
The molecular hallmarks of epigenetic control
Allis, C. D., & Jenuwein, T. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.59 · Cited by 2,809
The emerging role of epigenetic therapeutics in immuno-oncology
Topper, M. J., Vaz, M., Marrone, K. A., Brahmer, J. R., & Baylin, S. B. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0266-5 · Cited by 433
Self-citationEmerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Garg, P., Malhotra, J., Kulkarni, P., Horne, D., Salgia, R., & Singhal, S. S. (2024) · Cancers · doi:10.3390/cancers16132478 · Cited by 339
Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence
Vissers, M. C. M., & Das, A. B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00809 · Cited by 188
Metadata
- Authors
- Baylin, S. B., & Jones, P. A.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-05-18
- Volume
- 8
- Issue
- 9
- Pages
- a019505
- ISSN
- 1943-0264
- Cited by
- 1,226
- References
- 49
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epigenetic Determinants of Cancer. https://app.cochat.ai/papers/10.1101/cshperspect.a019505
- The paper
- Baylin, S. B., & Jones, P. A. (2016). Epigenetic Determinants of Cancer. Cold Spring Harbor Perspectives in Biology. https://doi.org/10.1101/cshperspect.a019505
